{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:12:49Z","timestamp":1778735569437,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00699-1","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:43:28Z","timestamp":1778733808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunophenotypic aberrancies in molecularly confirmed acute promyelocytic leukemia: lessons from two cases"],"prefix":"10.1007","volume":"19","author":[{"given":"Lumen Agarkar","family":"Prattipati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhee","family":"kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavya","family":"Ronanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem Venkatt","family":"Thangavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"23","key":"699_CR1","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.3390\/cancers16234092","volume":"16","author":"A Bidikian","year":"2024","unstructured":"Bidikian A, Bewersdorf JP, Kewan T, Stahl M, Zeidan AM (2024Dec 6) Acute promyelocytic leukemia in the real world: understanding outcome differences and how we can improve them. Cancers 16(23):4092","journal-title":"Cancers"},{"issue":"6","key":"699_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/hematolrep17060066","volume":"17","author":"M Abddaoui","year":"2025","unstructured":"Abddaoui M, Aghlallou Y, Tlem\u00e7ani I, Amrani HM (2025Nov 28) Acute promyelocytic leukemia: pathophysiology, diagnosis and clinical management. Hematol Rep 17(6):66","journal-title":"Hematol Rep"},{"issue":"4","key":"699_CR3","volume":"8","author":"S Kankhaw","year":"2025","unstructured":"Kankhaw S, Owattanapanich W, Promsuwicha O, Thong-Ou T, Ruchutrakool T, Khuhapinant A et al (2025) Immunophenotypic profiling of acute promyelocytic leukemia: insights from a large cohort. Cancer Rep 8(4):e70198","journal-title":"Cancer Rep"},{"issue":"5","key":"699_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2257.2005.00715.x","volume":"27","author":"K Kaito","year":"2005","unstructured":"Kaito K, Katayama T, Masuoka H, Nishiwaki K, Sano K, Sekiguchi N et al (2005) CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis. Clin Lab Haematol 27(5):307\u201311. https:\/\/doi.org\/10.1111\/j.1365-2257.2005.00715.x","journal-title":"Clin Lab Haematol"},{"issue":"1","key":"699_CR5","first-page":"8","volume":"63","author":"W Gorczyca","year":"2012","unstructured":"Gorczyca W (2012) Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping. Pol J Pathol Off J Pol Soc Pathol 63(1):8\u201317","journal-title":"Pol J Pathol Off J Pol Soc Pathol"},{"key":"699_CR6","doi-asserted-by":"crossref","unstructured":"Liu W, Xu J. Microgranular acute promyelocytic leukemia with expression of T-cell markers mimicking mixed-phenotype acute leukemia. Blood [Internet]. 2020;135(11):880\u2013880. Available from: https:\/\/ashpublications.org\/blood\/article\/135\/11\/880\/452656\/Microgranular-acute-promyelocytic-leukemia-with.\u00a0Accessed 11 Jan 2026","DOI":"10.1182\/blood.2019004434"},{"issue":"3","key":"699_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12308-018-0329-z","volume":"11","author":"ZN Singh","year":"2018","unstructured":"Singh ZN, Duong VH, Koka R, Zou Y, Sawhney S, Tang L et al (2018) High-risk acute promyelocytic leukemia with unusual T\/myeloid immunophenotype successfully treated with ATRA and arsenic trioxide-based regimen. J Hematop 11(3):67\u201374","journal-title":"J Hematop"},{"key":"699_CR8","unstructured":"Wood BL, Khoury JD (2024) Acute leukaemias of mixed or ambiguous lineage: introduction. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet]. Lyon (France): International Agency for Research on Cancer. (WHO classification of tumours series, 5th ed, vol 11). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/63.\u00a0Accessed 25 March 2026"},{"issue":"2","key":"699_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.leukres.2014.11.010","volume":"39","author":"CP Souza Melo","year":"2015","unstructured":"Souza Melo CP, Campos CB, Dutra \u00c1P, Neto JCA, Fenelon AJS, Neto AH et al (2015) Correlation between FLT3-ITD status and clinical, cellular and molecular profiles in promyelocytic acute leukemias. Leuk Res 39(2):131\u2013137","journal-title":"Leuk Res"},{"issue":"12","key":"699_CR10","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00277-014-2142-9","volume":"93","author":"AR Lucena-Araujo","year":"2014","unstructured":"Lucena-Araujo AR, Kim HT, Jacomo RH, Melo RA, Bittencourt R, Pasquini R et al (2014Dec) Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study. Ann Hematol 93(12):2001\u20132010","journal-title":"Ann Hematol"},{"issue":"11","key":"699_CR11","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1038\/sj.leu.2402723","volume":"16","author":"NI Noguera","year":"2002","unstructured":"Noguera NI, Breccia M, Divona M, Diverio D, Costa V, De Santis S et al (2002) Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia 16(11):2185\u20132189","journal-title":"Leukemia"},{"issue":"7","key":"699_CR12","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.leu.2403790","volume":"19","author":"C Callens","year":"2005","unstructured":"Callens C, Chevret S, Cayuela JM, Cassinat B, Raffoux E,","journal-title":"Leukemia"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00699-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00699-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00699-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:43:57Z","timestamp":1778733837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00699-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00699-1","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patients for publication of this case report.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.\u00a0","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study, consent for publication is not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"20"}}